| The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression W Su, HH Han, Y Wang, B Zhang, B Zhou, Y Cheng, A Rumandla, ... Cancer Cell, 2019 | 161 | 2019 |
| Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential S Gurrapu, E Pupo, G Franzolin, L Lanzetti, L Tamagnone Cell Death & Differentiation 25 (7), 1259, 2018 | 70 | 2018 |
| Transmembrane semaphorins: multimodal signaling cues in development and cancer S Gurrapu, L Tamagnone Cell adhesion & migration 10 (6), 675-691, 2016 | 48 | 2016 |
| Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ... Cell Reports 39 (1), 110595, 2022 | 28 | 2022 |
| Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells S Gurrapu, L Tamagnone Trends in molecular medicine, 2019 | 27 | 2019 |
| PlexinD1 is a novel transcriptional target and effector of notch signaling in cancer cells M Rehman, S Gurrapu, G Cagnoni, L Capparuccia, L Tamagnone PloS one 11 (10), e0164660, 2016 | 25 | 2016 |
| Reverse signaling by semaphorin 4C elicits SMAD1/5-and ID1/3-dependent invasive reprogramming in cancer cells S Gurrapu, G Franzolin, D Fard, M Accardo, E Medico, I Sarotto, A Sapino, ... Science Signaling 12 (595), eaav2041, 2019 | 21 | 2019 |
| Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts SD Darekar, M Mushtaq, S Gurrapu, L Kovalevska, C Drummond, ... Oncotarget 6 (25), 21016, 2015 | 19 | 2015 |
| 750 Malat1 lncRNA controls metastatic reactivation of dormant breast cancer by immune evasion D Kumar, S Gurrapu, H Han, Y Wang, S Bae, H Chen, CJ Wu, F Giancotti Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 4 | 2020 |
| LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells D Kumar, S Gurrapu, Y Wang, SY Bae, PR Pandey, H Chen, J Mondal, ... Nature Cancer, 1-21, 2024 | 1 | 2024 |
| SARS-CoV-2 exploits sexually dimorphic and adaptive IFN and TNFa signaling to gain entry into alveolar epithelium Y Wang, S Gurrapu, H Chen, S Laudato, E Caggiano, Y Jiang, HH Ling, ... bioRxiv, 2021 | 1 | 2021 |
| Inhibition of cGAS as a strategy to restore anti-tumor immunity response to STING agonist in chromosomally unstable tumors C Hong, L Caprio, M Duran, M Rogava, HH Ling, S Gurrapu, L Ebel, ... Cancer Research 84 (6_Supplement), 6598-6598, 2024 | | 2024 |
| Elucidating the Niche Microenvironments of Dormant and Metastatic Breast Cancers N Meher, S Gurrapu, MD Giancotti, G Filippo The University of Texas MD Anderson Cancer Center, 2021 | | 2021 |
| SARS-CoV-2 Exploits Sexually Dimorphic and Adaptive IFN and TNFa Signaling to Gain Entry into Alveolar Epithelium F Giancotti, Y Wang, S Gurrapu, H Chen, S Laudato, E Caggiano, Y Jiang, ... bioRxiv, 2021 | | 2021 |
| Transcriptional Inactivation of TP53 and the BMP Pathway Mediates Therapy-induced Dedifferentiation and Metastasis in Prostate Cancer H Han, Y Wang, JN Curto, S Gurrapu, S Laudato, A Rumandla, ... bioRxiv, 2021 | | 2021 |
| Androgen receptor blockade induces reprogramming to mesenchymal and stem-like prostate cancer and dependency on HER2/3 signaling. H Han, Y Wang, A Rumandla, S Laudato, JC Navarro, S Gurrapu, ... CANCER RESEARCH 80 (11), 31-32, 2020 | | 2020 |
| The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression S Wenjing, HH Han, W Yan, Z Boyu, C Yuanming, A Rumandla, ... | | 2019 |
Filippo GiancottiColumbia University Comprehensive Cancer CenterVerified email at cumc.columbia.edu
